This assessment shows 29 of 41 FAIR indicators are evaluable in NFDI4Health's metadata schema, indicating usability improvements are needed.
Objectives: The German National Research Data Infrastructure for Personal Health Data (NFDI4Health) has developed a metadata schema (MDS) for harmonizing health study descriptions, along with a platform for content discovery. This work evaluates how well the MDS promotes FAIR data principles (Findability, Accessibility, Interoperability, Reusability) and serves as a proxy for assessing study FAIRness. Materials and Methods: Using the Research Data Alliance's 'FAIR data maturity model', we assessed the scope of evaluable FAIRness indicators for NFDI4Health's MDS (version 3.3). Results: 29 of 41 FAIRness indicators can be evaluated (Findability: 7/7, Interoperability: 7/12, Accessibility: 7/12, Reusability: 8/10). The remaining indicators relate to the research data's format and access procedures. Discussion: The MDS provides a viable basis for evaluating study FAIRness. To enable full indicator coverage, additional metadata elements should be incorporated. Conclusion: NFDI4Health's MDS effectively promotes FAIR-compliant study descriptions, although adjustments could strengthen its utility for assessing research data FAIRness.
No takes yet. Share an insight, caveat, or question.
Kasbohm et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: